|
US5639724A
(en)
*
|
1984-07-24 |
1997-06-17 |
Sandoz Ltd. |
Cyclosporin galenic forms
|
|
US5342625A
(en)
*
|
1988-09-16 |
1994-08-30 |
Sandoz Ltd. |
Pharmaceutical compositions comprising cyclosporins
|
|
US6007840A
(en)
*
|
1988-09-16 |
1999-12-28 |
Novartis Ag |
Pharmaceutical compositions comprising cyclosporins
|
|
GB2222770B
(en)
*
|
1988-09-16 |
1992-07-29 |
Sandoz Ltd |
Pharmaceutical compositions containing cyclosporins
|
|
US7081445B2
(en)
*
|
1989-02-20 |
2006-07-25 |
Novartis Ag |
Cyclosporin galenic forms
|
|
US5294604A
(en)
*
|
1989-12-20 |
1994-03-15 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Method of treating ocular diseases by periocular administration of cyclosporine A or G
|
|
DE69129918T2
(de)
*
|
1990-03-23 |
1999-02-04 |
Yoshitomi Pharmaceutical Industries, Ltd., Osaka |
Ein in Wasser schwerlösliches Arzneimittel enthaltende pharmazeutische Zubereitung
|
|
JPH06508029A
(ja)
*
|
1991-05-17 |
1994-09-14 |
カイロン コーポレイション |
NF−↓kB転写活性化物質のインヒビター及びその使用
|
|
US6262022B1
(en)
|
1992-06-25 |
2001-07-17 |
Novartis Ag |
Pharmaceutical compositions containing cyclosporin as the active agent
|
|
ES2098739T3
(es)
|
1992-05-13 |
1997-05-01 |
Sandoz Ltd |
Composiciones oftalmicas conteniendo una cyclosporin.
|
|
DK0589843T3
(da)
|
1992-09-25 |
2002-04-02 |
Novartis Ag |
Cyclosporinholdige farmaceutiske præparater
|
|
WO1994008538A1
(fr)
*
|
1992-10-22 |
1994-04-28 |
Aktsionernoe Obschestvo 'olvik' |
Membrane oculaire medicinale et son procede de production
|
|
HUT72738A
(en)
†
|
1993-04-20 |
1996-05-28 |
Rentschler Arzneimittel |
New cyclosporine-containing pharmaceutical compositions for oral administration
|
|
DE4322826A1
(de)
*
|
1993-07-08 |
1995-01-12 |
Galenik Labor Freiburg Gmbh |
Pharmazeutisches Präparat
|
|
US20020099067A1
(en)
*
|
1993-07-08 |
2002-07-25 |
Ulrich Posanski |
Pharmaceutical compositions for sparingly soluble therapeutic agents
|
|
EP1033128B2
(en)
*
|
1993-09-28 |
2011-11-23 |
R.P. Scherer GmbH |
Soft gelatin capsule manufacture
|
|
TW349870B
(en)
*
|
1993-09-30 |
1999-01-11 |
Janssen Pharmaceutica Nv |
An antifungal pharmaceutical composition for oral administration and a process for the preparation thereof
|
|
FR2711982B1
(fr)
*
|
1993-11-02 |
1996-01-19 |
Saint Gobain Vitrage |
Canal de transfert et de conditionnement de verre en fusion.
|
|
AU696855B2
(en)
*
|
1994-03-18 |
1998-09-17 |
Shire Laboratories, Inc. |
Emulsified drug delivery systems
|
|
US5474979A
(en)
*
|
1994-05-17 |
1995-12-12 |
Allergan, Inc. |
Nonirritating emulsions for sensitive tissue
|
|
EP0789580B1
(de)
|
1994-11-03 |
2002-06-05 |
Novartis AG |
Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
|
|
US5824638A
(en)
*
|
1995-05-22 |
1998-10-20 |
Shire Laboratories, Inc. |
Oral insulin delivery
|
|
US5766629A
(en)
|
1995-08-25 |
1998-06-16 |
Sangstat Medical Corporation |
Oral cyclosporin formulations
|
|
US5962019A
(en)
*
|
1995-08-25 |
1999-10-05 |
Sangstat Medical Corporation |
Oral cyclosporin formulations
|
|
US5834017A
(en)
*
|
1995-08-25 |
1998-11-10 |
Sangstat Medical Corporation |
Oral cyclopsporin formulations
|
|
US5827822A
(en)
*
|
1996-03-25 |
1998-10-27 |
Sangstat Medical Corporation |
Cyclosporin a formulations as nanoparticles
|
|
EP0760237A1
(en)
*
|
1995-08-30 |
1997-03-05 |
Cipla Limited |
Oil-in-water microemulsions
|
|
DE19549852B4
(de)
|
1995-11-29 |
2009-06-04 |
Novartis Ag |
Cyclosporin enthaltende Präparate
|
|
CZ288631B6
(cs)
*
|
1996-01-18 |
2001-08-15 |
Galena, A. S. |
Léčivé přípravky s obsahem cyklosporinu
|
|
US5858401A
(en)
|
1996-01-22 |
1999-01-12 |
Sidmak Laboratories, Inc. |
Pharmaceutical composition for cyclosporines
|
|
US5660858A
(en)
*
|
1996-04-03 |
1997-08-26 |
Research Triangle Pharmaceuticals |
Cyclosporin emulsions
|
|
KR100542816B1
(ko)
|
1996-08-22 |
2006-01-11 |
알티피 파마 코포레이션 |
수불용성 물질의 미립자를 포함하는 조성물 및 이것의 제조 방법
|
|
US7255877B2
(en)
*
|
1996-08-22 |
2007-08-14 |
Jagotec Ag |
Fenofibrate microparticles
|
|
US6465016B2
(en)
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
|
KR20040004416A
(ko)
*
|
1997-01-30 |
2004-01-13 |
노파르티스 아게 |
오일을 함유하지 않은 사이클로스포린 a 함유 제약 조성물
|
|
DE19724605A1
(de)
*
|
1997-06-11 |
1998-12-17 |
Sueddeutsche Kalkstickstoff |
Hydrophile, homogene Monogycerid-Formulierungen und Verfahren zu deren Herstellung
|
|
US6187747B1
(en)
|
1997-09-08 |
2001-02-13 |
Panacea Biotech Limited |
Pharmaceutical composition comprising cyclosporin
|
|
US6346511B1
(en)
|
1997-09-08 |
2002-02-12 |
Panacea Biotec Limited |
Pharmaceutical composition comprising cyclosporin
|
|
IN188719B
(OSRAM)
*
|
1997-09-08 |
2002-11-02 |
Panacea Biotec Ltd |
|
|
US6008191A
(en)
*
|
1997-09-08 |
1999-12-28 |
Panacea Biotec Limited |
Pharmaceutical compositions containing cyclosporin
|
|
AU743098B2
(en)
|
1997-12-10 |
2002-01-17 |
Cyclosporine Therapeutics Limited |
Pharmaceutical compositions containing an omega-3 fatty acid oil
|
|
DE19810655A1
(de)
*
|
1998-03-12 |
1999-09-16 |
Univ Eberhard Karls |
Arzneimittel mit einem Gehalt an Ciclosporin
|
|
US6979456B1
(en)
|
1998-04-01 |
2005-12-27 |
Jagotec Ag |
Anticancer compositions
|
|
CN1245955C
(zh)
|
1998-05-29 |
2006-03-22 |
斯凯伊药品加拿大公司 |
热保护微粒组合物及其最终蒸汽灭菌的方法
|
|
EP0976394A1
(en)
*
|
1998-07-30 |
2000-02-02 |
Biosearch Italia S.p.A. |
New injectable formulations
|
|
KR20010073232A
(ko)
|
1998-11-20 |
2001-07-31 |
추후제출 |
분산성 인지질로 안정화된 마이크로입자
|
|
CA2354233A1
(en)
*
|
1998-12-11 |
2000-06-15 |
Pharmasolutions, Inc. |
Self-emulsifying compositions for drugs poorly soluble in water
|
|
US6447806B1
(en)
|
1999-02-25 |
2002-09-10 |
Novartis Ag |
Pharmaceutical compositions comprised of stabilized peptide particles
|
|
US6057289A
(en)
*
|
1999-04-30 |
2000-05-02 |
Pharmasolutions, Inc. |
Pharmaceutical composition comprising cyclosporin in association with a carrier in a self-emulsifying drug delivery system
|
|
EP1214059B1
(en)
*
|
1999-09-21 |
2005-05-25 |
Skyepharma Canada Inc. |
Surface modified particulate compositions of biologically active substances
|
|
US6720001B2
(en)
|
1999-10-18 |
2004-04-13 |
Lipocine, Inc. |
Emulsion compositions for polyfunctional active ingredients
|
|
AU2127400A
(en)
*
|
1999-11-02 |
2001-05-14 |
Cipla Limited |
A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and process for preparation thereof
|
|
US7732404B2
(en)
*
|
1999-12-30 |
2010-06-08 |
Dexcel Ltd |
Pro-nanodispersion for the delivery of cyclosporin
|
|
GB0008785D0
(en)
*
|
2000-04-10 |
2000-05-31 |
Novartis Ag |
Organic compounds
|
|
US8586094B2
(en)
*
|
2000-09-20 |
2013-11-19 |
Jagotec Ag |
Coated tablets
|
|
US20020058065A1
(en)
*
|
2000-09-20 |
2002-05-16 |
Pol-Henri Guivarc'h |
Insoluble drug particle compositions with improved fasted-fed effects
|
|
ES2330625T3
(es)
*
|
2001-10-19 |
2009-12-14 |
Isotechnika Inc. |
Preconcentrados de microemulsion de analogos de ciclosporina novedosos.
|
|
US6979672B2
(en)
|
2002-12-20 |
2005-12-27 |
Polichem, S.A. |
Cyclosporin-based pharmaceutical compositions
|
|
US20050059583A1
(en)
|
2003-09-15 |
2005-03-17 |
Allergan, Inc. |
Methods of providing therapeutic effects using cyclosporin components
|
|
US7135455B2
(en)
*
|
2004-11-15 |
2006-11-14 |
Allergan, Inc |
Methods for the therapeutic use of cyclosporine components
|
|
US7151085B2
(en)
*
|
2004-11-15 |
2006-12-19 |
Allergan, Inc. |
Therapeutic methods using cyclosporine components
|
|
EP1885342B8
(en)
*
|
2005-03-21 |
2016-06-22 |
Teva Czech Industries s.r.o. |
Crystallization inhibitor and its use in gelatin capsules
|
|
GB2451811A
(en)
|
2007-08-09 |
2009-02-18 |
Ems Sa |
Delivery composition for solubilising water-insoluble pharmaceutical active ingredients
|
|
ES2973062T3
(es)
|
2011-03-11 |
2024-06-18 |
Beth Israel Deaconess Medical Ct Inc |
Anticuerpos anti-CD40 y usos de los mismos
|
|
WO2016049282A1
(en)
|
2014-09-26 |
2016-03-31 |
The Chemours Company Fc, Llc |
Sulfonated fluorinated, non-fluorinated or partially fluorinated urethanes
|
|
EP3307322B1
(en)
|
2015-09-04 |
2021-02-17 |
Primatope Therapeutics Inc. |
Humanized anti-cd40 antibodies and uses thereof
|